tasimelteon
VP-VEC-162-3202
Phase 3 small_molecule active
Quick answer
tasimelteon for Non 24 Hour Sleep Wake Disorder is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Non 24 Hour Sleep Wake Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active